Foundation for Opioid Response Efforts (FORE) Announces $4.8 Million in New Grants to Support Innovative Solutions to the Opioid and Overdose Crisis
February 01, 2022 10:00 ET
|
Foundation for Opioid Response Efforts
New York, Feb. 01, 2022 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE), a private 501(c)(3) national grant-making foundation focused on ending the nation’s opioid crisis, is...
Foundation for Opioid Response Efforts (FORE) Issues Annual Report Outlining Approaches for Addressing the US Opioid Crisis
January 19, 2022 10:43 ET
|
Foundation for Opioid Response Efforts
New York, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The numbers are tragic and frightening: Deaths from drug overdoses are at an all-time high, with 255 Americans dying every day of an overdose. This grim...
The Reverend Dr. LaKeesha Walrond Joins Board of Directors of Foundation for Opioid Response Efforts (FORE)
September 22, 2021 11:16 ET
|
Foundation for Opioid Response Efforts
New York, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced that The Reverend Dr. LaKeesha Walrond, President of the New York Theological Seminary...
Peer Support Responder - A New Community Initiative That Provides FREE Specialized Training and Supplies to People Likely to Encounter an Opioid Overdose
July 27, 2021 09:03 ET
|
Heart to Heart First Aid CPR Services Inc
TORONTO, July 27, 2021 (GLOBE NEWSWIRE) -- As of today, Heart to Heart CPR has completed Phase 1 of their Peer Support Responder program that provides free advanced overdose training and protective...
One in three Canadians lack proper knowledge on where to safely dispose of unused or unwanted medications and sharps
July 14, 2021 09:00 ET
|
Health Products Stewardship Association
TORONTO, July 14, 2021 (GLOBE NEWSWIRE) -- Today, the Health Products Stewardship Association (HPSA) - a national not-for-profit that operates return programs for unused or unwanted medications and...
Trevena Announces NIH Has Resumed Recruiting Patients in Proof-of-Concept Study for TRV734 in Opioid Use Disorder
June 16, 2021 07:00 ET
|
Trevena Inc.
-- TRV734 reduced drug-seeking behavior in a preclinical model of relapse, suggesting its utility as a novel oral maintenance treatment for opioid use disorder The study is being conducted and...
SHAREHOLDER ALERT: Lowey Dannenberg Is Investigating Walmart Inc. for Potential Breaches of Fiduciary Duty by Its Board of Directors
January 13, 2021 16:27 ET
|
Lowey Dannenberg, P.C.
NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim...
Spark Biomedical’s Sparrow Therapy System™ receives FDA Clearance for Opioid Withdrawal Relief in Adults
January 04, 2021 16:38 ET
|
Spark Biomedical
Dallas, TX, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc. announced today that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to The Sparrow Therapy System, a...
Emergent BioSolutions Teams Up with Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and MAPDA to Highlight Importance of Overdose Reversal Medicines on International Overdose Awareness Day
August 31, 2020 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it is teaming up with the Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and...
Nine Foremost Pain Management Physicians Join the Spark Biomedical, Inc. Medical Advisory Board
August 28, 2020 09:30 ET
|
Spark Biomedical
Dallas, Texas, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Spark Biomedical, developer of the Sparrow ™ Therapy System — a discrete, wearable, over-the-ear, medical device designed for opioid withdrawal...